Cells

Human Primary Diabetic Gallbladder Epithelial Cells

NBPE004 Cells
$900.00
Human Primary Diabetic Gallbladder Epithelial Cells
In Stock 1 Vial — 500,000 cells
Product Type Human Type II Diabetes E…
Viability >95% viable (Trypan Blue exclusion)
Storage Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included

Product Overview

Description

Human Primary Diabetic Gallbladder Epithelial Cells are cryopreserved primary human epithelial cells intended for in vitro research on diabetes-associated cellular dysfunction. The product is supplied as an early-passage culture and is designed for mechanistic studies, disease modeling, assay development, and pharmacology. The scientific profile emphasizes preservation of tissue-relevant phenotype while minimizing passage-related drift.

Guarantee expansion for a minimum of 2-5 population
doublings.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features

Catalog Number: NBPE004
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

Characterization Markers 

Positive for endothelial markers: Positive for epithelial
markers: E-cadherin and/or ZO-1 (tight junction protein) by
immunofluorescence staining .

- Isolated using EpCAM-1 (CD326) antibody with magnetic beads to ensure epithelial purity

Quick Facts
Product Type

Human Type II Diabetes Endothelial Cells

Viability

>95% viable (Trypan Blue exclusion)

Applications

Diabetic Cholecystopathy: Studying the mechanisms…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Proliferative Capability
Primary cells capable of multiple passages when using recommended medium and proper handling
Storage Conditions
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
NBPE004
Size/Format
1 Vial — 500,000 cells
Primary Applications
Diabetic Cholecystopathy: Studying the mechanisms behind gallbladder distension stasis and the increased risk of acute acalculous cholecystitis in diabetics. Gallstone Pathogenesis: Investigating how hyperglycemia affects mucin (MUC5AC MUC2) overproduction which acts as a nidus for cholesterol crystallization. Fibrosis and Remodeling: Understanding the epithelial-to-mesenchymal transition (EMT) in diabetic patients which contributes to gallbladder fibrosis and contractile dysfunction. Drug Toxicity: Testing the hepatobiliary toxicity of new anti-diabetic medications (such as SGLT2 inhibitors or GLP-1 agonists) on human-specific epithelial barriers.

Applications & Use Cases

Primary Applications
Diabetic Cholecystopathy: Studying the mechanisms behind gallbladder distension

Suitable for diabetic cholecystopathy: studying the mechanisms behind gallbladder distension studies and research applications

stasis

Suitable for stasis studies and research applications

and the increased risk of acute acalculous cholecystitis in diabetics. Gallstone Pathogenesis: Investigating how hyperglycemia affects mucin (MUC5AC

Suitable for and the increased risk of acute acalculous cholecystitis in diabetics. gallstone pathogenesis: investigating how hyperglycemia affects mucin (muc5ac studies and research applications

MUC2) overproduction

Suitable for muc2) overproduction studies and research applications

which acts as a nidus for cholesterol crystallization. Fibrosis and Remodeling: Understanding the epithelial-to-mesenchymal transition (EMT) in diabetic patients

Suitable for which acts as a nidus for cholesterol crystallization. fibrosis and remodeling: understanding the epithelial-to-mesenchymal transition (emt) in diabetic patients studies and research applications

which contributes to gallbladder fibrosis and contractile dysfunction. Drug Toxicity: Testing the hepatobiliary toxicity of new anti-diabetic medications (such as SGLT2 inhibitors or GLP-1 agonists) on human-specific epithelial barriers.

Suitable for which contributes to gallbladder fibrosis and contractile dysfunction. drug toxicity: testing the hepatobiliary toxicity of new anti-diabetic medications (such as sglt2 inhibitors or glp-1 agonists) on human-specific epithelial barriers. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Our Worldwide Locations

Find a distributor near you

Harmony Biosolution Inc.

Harmony Biosolution Inc.

Address 1F., No. 309-4, Sec. 1,
Wenhua Rd.,
Banqiao Dist.,, New Taipei City, 220
Taiwan
MoreBio

MoreBio

Advancing Life Science, Globally

Address F810, Testa Tower, 25, Misagangbyeonseo-ro
Hanam-si, Gyeonggi-do, Republic of Korea, 12918
Korea
Contact yhwoo@morebio.co.kr
+82-2-406-2942
+82-31-735-2944